ASND icon

Ascendis Pharma

35 hedge funds and large institutions have $585M invested in Ascendis Pharma in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.87%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.17%
New
8
Increased
10
Reduced
12
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
AG
26
Aperio Group
California
$203K +$203K +7,242 New
Bank of America
27
Bank of America
North Carolina
$150K +$28.6K +1,020 +24%
Victory Capital Management
28
Victory Capital Management
Texas
$144K +$144K +5,158 New
Wells Fargo
29
Wells Fargo
California
$143K -$4.12K -147 -3%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$56K +$56K +1,994 New
TRCT
31
Tower Research Capital (TRC)
New York
$32K +$14.8K +524 +86%
UBS Group
32
UBS Group
Switzerland
$27K +$21.4K +759 +380%
Creative Planning
33
Creative Planning
Kansas
$10K +$10K +350 New
US Bancorp
34
US Bancorp
Minnesota
$2K
Deutsche Bank
35
Deutsche Bank
Germany
$2K +$2K +100 New
NC
36
Nexthera Capital
New York
-$2.02M -100,000 Closed
Marshall Wace
37
Marshall Wace
United Kingdom
-$1.77M -87,558 Closed
LCM
38
Laurion Capital Management
New York
-$1.68M -83,200 Closed